Keros Therapeutics, Inc. · NASDAQ:KROS
BlackRock Portfolio Management LLC reported a 5.70% stake in Keros Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 17, 2026
BlackRock Portfolio Management LLC reported a 5.70% stake in Keros Therapeutics, Inc., 1,122,874 shares, as a passive investor on Jun 30, 2026. Filed Jul 17, 2026 (Schedule 13G).
- Stake
- 5.70%
- Shares
- 1,122,874
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock Portfolio Management LLC | 5.70% | 1,122,874 |